학술논문
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes
Document Type
Article
Author
Source
In Molecular Metabolism September 2021 51
Subject
Language
ISSN
2212-8778